NBMI, what used to be called OSR#1, starts the next step for approval to come back on the market. NBMI was approved by the Ministry of Health in Ecuador for Phase 2 efficacy trials on mercury poisoned gold miners. The study will start in a few weeks and the first data should be available by November, 2015. Based on the excellent results obtained in the Phase 1 studies on poisoned animals, we expect great results.
The reason for choosing Ecuador is to make it possible to show efficacy on people with clear clinical symptoms of mercury poisoning. This country and 70 other countries use 1,400 tonnes of mercury to extract gold from the soil. They heat a gold-mercury amalgam, which releases toxic mercury vapor, which the miners breath into their bodies. The test region has the highest incidence of dwarfism, colon cancer, and spontaneous abortions in Ecuador.
The MBMI is simply a very unusual drug that chelates out the heavy metals powerfully and fast, helps a variety of diseases and yet has no significant side effects. Of course we already know this from the OSR#1 days.
Look for future updates to know when this powerful, safe chelator will become available to the public again.
Print